Skip to main content

Occurrence of Selected Generic Drugs 13

Basic Details
Date Posted
Status
Complete
Medical Product
amlodipine besylate
efalizumab
ibandronate sodium
lamotrigine
leflunomide
maraviroc
metoclopramide HCL
nitrofurantoin
nitrofurantoin macrocrystal
nitrofurantoin monohyd/m-crystal
propylthiouracil
quinine
quinine sulfate
ramipril
rosiglitazone maleate
sibutramine HCL m-hydrate
tadalafil
varenicline tartrate
Description

These reports look at use of 18 selected generic drug products (efalizumab, leflunomide, propylthiouracil, rosiglitazone maleate, lamotrigine, metoclopramide HCL, nitrofurantoin, nitrofurantoin macrocrystal, nitrofurantoin monohyd/m-crystal, quinine, quinine sulfate, varenicline tartrate, sibutramine HCL m-hydrate, amlodipine besylate, ibandronate sodium, maraviroc, ramipril, and tadalafil) in the Mini-Sentinel Distributed Database (MSDD). This query was distributed to Data Partners on September 13, 2012. 

Deliverables (2)
Mini-Sentinel Summary Table Report: Occurrence of Selected Generic Drugs 13, Report 1 Mini-Sentinel Summary Table Report: Occurrence of Selected Generic Drugs 13, Report 2
Additional Details
FDA Center
CDER
Time Period
2004 - 2011
Analysis Type
Summary Table
Population / Cohort
All individuals
Data Sources
Mini-Sentinel Distributed Database (MSDD)